LLY · ELI LILLY & Co

$1,180.16 -28.84 (-2.39%) At close · Aug 14

Market Cap

$1.11T

941.36M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,700,000	—	$23,325,000	—	$6,485,500	$736,201	$36,698,337
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs	$1,490,385	—	$12,000,000	—	$3,249,039	$159,307	$17,786,576
Anat Hakim	Executive Vice President, General Counsel and Secretary	$1,000,000	—	$6,000,000	—	$2,180,000	$162,570	$9,845,518
Lucas Montarce	Executive Vice President and Chief Financial Officer	$1,000,000	—	$5,000,000	—	$2,180,000	$60,000	$8,483,315
Jake Van Naarden	Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development	$920,192	—	$4,500,000	—	$2,006,019	$72,519	$7,586,097

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,690,385	—	$19,749,324	—	$5,705,049	$351,685	$29,242,926
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,430,769	—	$7,499,895	—	$3,219,230	$206,980	$12,638,744
Anat Hakim	Executive Vice President, General Counsel and Secretary	$1,000,000	—	$3,950,071	—	$2,250,000	$66,834	$7,478,426
Jake Van Naarden	Executive Vice President and President, Loxo@Lilly	$890,385	—	$2,700,248	—	$2,003,366	$113,062	$5,773,948
Anat Ashkenazi	Executive Vice President and Chief Financial Officer	$634,039	—	$3,750,501	—	—	$38,042	$4,961,459
Lucas Montarce	Executive Vice President and Chief Financial Officer	$664,639	—	$1,067,135	—	$1,114,558	$39,878	$2,948,519
Gordon Brooks	Interim CFO and Group Vice President - Controller and Corporate Strategy	$558,291	$50,000	$1,300,190	—	$667,660	$33,497	$2,740,458

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,621,154	—	$18,840,250	—	$4,401,433	$263,073	$26,565,732
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,330,769	—	$7,483,400	—	$2,408,692	$79,846	$11,853,929
Anat Ashkenazi	Executive Vice President and Chief Financial Officer	$1,030,769	—	$3,689,000	—	$1,865,692	$61,846	$7,599,257
Anat Hakim	Executive Vice President, General Counsel and Secretary	$980,769	—	$3,952,500	—	$1,775,192	$58,846	$7,006,737
Jake Van Naarden	Executive Vice President and President, Loxo@Lilly	$830,769	—	$2,424,200	—	$1,503,692	$49,846	$4,886,520

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,500,000	—	$16,981,250	—	$2,700,000	$216,885	$21,398,135
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,201,923	—	$5,747,500	—	$1,442,308	$72,115	$8,463,846
Anat Hakim	Executive Vice President, General Counsel and Secretary	$875,962	—	$3,135,000	—	$1,051,154	$52,558	$5,261,466
Anat Ashkenazi	Executive Vice President and Chief Financial Officer	$940,385	—	$3,135,000	—	$1,128,462	$56,423	$5,260,270
Patrik Jonsson	Executive Vice President and President, Lilly Immunology, Lilly USA and Chief Customer Officer	$740,385	$0	$2,194,500	—	$888,462	$44,423	$3,923,265
Jake Van Naarden	Executive Vice President and President, Loxo@Lilly	$735,577	—	$1,933,250	—	$882,692	$44,135	$3,621,832

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,500,000	$0	$14,966,000	—	$2,475,000	$126,750	$21,509,985
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	$1,000,000	$0	$5,024,300	—	$1,100,000	$60,000	$7,527,092
Jake Van Naarden	Executive Vice President and President, Loxo@Lilly	$745,649	$218,715	$4,099,500	—	$1,029,507	$12,462	$6,122,742
Jacob Van Naarden	Senior Vice President, CEO Loxo Oncology at Lilly and President, Lilly Oncology	$745,649	$218,715	$4,099,500	—	$1,029,507	$12,462	$6,122,742
Diogo Rau	Senior Vice President and Chief Information and Digital Officer	$412,308	$250,000	$4,000,000	—	$362,831	$31,670	$5,101,328
Anat Ashkenazi	Executive Vice President and Chief Financial Officer	$850,432	$0	$2,453,000	—	$906,894	$51,026	$4,656,687
Anat Hakim	Executive Vice President, General Counsel and Secretary	$775,000	$0	$2,244,900	—	$852,500	$46,500	$4,017,853
Joshua L. Smiley	Former Senior Vice President and Chief Financial Officer	$230,831	$0	$0	—	$0	$13,850	$244,681

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,483,333	$0	$13,587,500	—	$2,625,500	$128,372	$23,708,629
Daniel Skovronsky	M.D., Ph.D. Executive Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories	$983,333	$0	$4,456,700	—	$1,102,317	$58,539	$7,352,112
Joshua L. Smiley	Former Senior Vice President and Chief Financial Officer	$983,333	$0	$3,587,100	—	$0	$58,539	$7,314,248
Alfonso G. Zulueta	Senior Vice President and President, Lilly International	$850,000	$0	$2,445,750	$0	$952,850	$50,608	$6,567,477
Anat Hakim	Executive Vice President, General Counsel and Secretary	$710,417	$150,000	$4,174,043	—	$670,633	$124,958	$5,917,899

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chair, President, and Chief Executive Officer	$1,400,000	$0	$12,222,000	—	$2,919,000	$84,000	$21,283,242
Joshua L. Smiley	Former Senior Vice President and Chief Financial Officer	$895,833	$0	$3,142,800	—	$1,182,948	$53,750	$7,348,401
Daniel Skovronsky	M.D., Ph.D. Senior Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories	$900,000	$0	$4,074,000	—	$1,188,450	$54,000	$6,662,971

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Ricks	Chairman, President, and Chief Executive Officer	$1,400,000	$0	$10,584,000	$0	$3,633,000	$84,000	$17,230,337
Joshua L. Smiley	Former Senior Vice President and Chief Financial Officer	$875,000	$0	$2,704,800	$0	$1,438,063	$52,500	$5,245,343
Daniel Skovronsky	M.D., Ph.D. Senior Vice President, Chief Scientific Officer, and President, Lilly Research Laboratories	$837,500	$0	$2,806,000	$0	$1,376,431	$50,250	$5,145,898

Executive changes

Person	Role	Change	Effective	Filed
Carolyn R. Bertozzi	member of the Board	Appointed	2025-12-08	2025-11-21
Karen Walker	member of the Board	Resigned	2024-12-31	2024-11-19
Jon Moeller	member of the Board	Appointed	2024-12-01	2024-11-19
Lucas Montarce	executive vice president and chief financial officer	Appointed	2024-09-09	2024-09-09
Marschall S. Runge	independent director	Retired	2024-08-31	2024-08-16
Gordon Brooks	interim chief financial officer	Appointed	2024-07-15	2024-07-10

Key facts CIK 59478 CUSIP 532457108 13F (30d) 3872 filings 3792 filers Visit website Investor relations